Sarepta Therapeutics (SRPT)

[k+the+new+investor]

Hi,

I am so glad for all the DMD boys who will benefit from this! My nephew has DMD. Although the exon skipping eteplirsen does will not help him. (I forget which exon he would need to address) but it is another number.

BUT there is also a company called Summit Therapeutics that has a drug that helps muscles (does not produce dystropin but utrophin, dystophin gets produced when body stops producing utrophin ) that may help ALL DMD boys. I am no scientist, but see the link below.

So although SRPT has no competition pe se, I think that Summit will also be in the field and may impact SRPT. I think I will put more $ into SRPT, but also SMMT.


Here is an old article (fr April) but it helps explain things.

http://marketexclusive.com/summit-therapeutics-plc-adr-nasdaqsmmt-spanner-sarepta-therapeutics-incs-nasdaqsrpt-works/6082/

Interested in any thoughts on how SMMT will affect SRPT, or vica versa?